Squarepoint Ops LLC - KEROS THERAPEUTICS INC ownership

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 83 filers reported holding KEROS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of KEROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$749,000
+53.2%
19,919
+12.4%
0.00%
+33.3%
Q2 2022$489,000
-23.2%
17,715
+96.1%
0.00%
-40.0%
Q4 2020$637,0009,0350.01%
Other shareholders
KEROS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 407,633$12,995,3405.15%
Opaleye Management Inc. 360,400$11,489,5523.74%
Parkman Healthcare Partners LLC 298,475$9,515,3831.74%
BRAIDWELL LP 1,357,309$43,271,0111.37%
First Light Asset Management, LLC 421,438$13,435,4431.28%
Orbimed Advisors 1,514,734$48,289,7201.03%
Yiheng Capital Management, L.P. 554,151$17,666,3340.90%
Nantahala Capital Management 328,781$10,481,5380.90%
DAFNA Capital Management LLC 65,961$2,102,8370.65%
EDBI Pte Ltd 10,105$322,1470.35%
View complete list of KEROS THERAPEUTICS INC shareholders